Ca2+-Calmodulin-dependent Protein Kinase II Plays a Major Role in Halothane-induced Dose-dependent Relaxation in the Skinned Pulmonary Artery

2002 ◽  
Vol 97 (1) ◽  
pp. 207-214 ◽  
Author(s):  
Judy Y. Su ◽  
Anhkiet C. Vo

Background Previously, the authors have shown in Ca(2+)-clamped skinned arterial strips that protein kinase C (PKC) plays a role in 3% halothane- or isoflurane-increased force. PKC in the pulmonary artery and Ca(2+)-calmodulin-dependent protein kinase II (CaMKII) in the femoral artery have been implicated in isoflurane-induced relaxation. For this study, the authors used clinical concentrations of halothane to examine the role of PKC and CaMKII in the halothane-induced biphasic effect on contraction in skinned pulmonary arterial strips. Methods Rabbit pulmonary arterial strips were mounted on force transducers and treated with saponin to make the sarcolemma permeable ("skinning"). Skinned strips were activated by low Ca(2+) (pCa 6.3) buffered with 7 mm EGTA, or the PKC activator phorbol-12,13-dibutyrate (PDBu, 1 microm) until force reached a steady state (control). Halothane (1, 2, and 3%) was administered, and the force was observed at peak and 15 min (test results). Ca(2+) ionophore (A23187, 10 microm) and inhibitors were preincubated in a relaxing solution and present in subsequent contracting solutions. Inhibitors were bisindolylmaleimide and Gö6976 for PKC, and KN-93 and the inhibitor protein (CKIINtide) for CaMKII. Results Halothane (1-3%) dose-dependently caused an initial increase (18-35%) and a subsequent decrease (48-68%) in pCa 6.3-induced force. Bisindolylmaleimide, 3 and 10 microm, completely blocked the increase in force at 2% and 3% halothane, respectively. CKIINtide, 0.1 microm, reduced the force at 3% halothane. The decrease in force at 1% and 2% halothane was partially prevented by 0.01 microm bisindolylmaleimide, and at 1, 2, and 3% halothane by 0.01, 0.1, and 1 microm CKIINtide, respectively. At 3% halothane, the increased force was abolished by A23187. In PDBu-induced force, 3% halothane-induced relaxation was also partially prevented by lower concentrations of KN-93 and CKIINtide. Conclusions In skinned pulmonary arterial strips, the dose-dependent increase in force by halothane is associated with PKC activation, and that of decrease is associated with CaMKII activation.

2003 ◽  
Vol 284 (6) ◽  
pp. H2311-H2319 ◽  
Author(s):  
Jean-Christophe Schneider ◽  
Driss El Kebir ◽  
Christiane Chéreau ◽  
Sophie Lanone ◽  
Xiao-Lin Huang ◽  
...  

Nitric oxide (NO) is synthesized froml-arginine by the Ca2+/calmodulin-sensitive endothelial NO synthase (NOS) isoform (eNOS). The present study assesses the role of Ca2+/calmodulin-dependent protein kinase II (CaMK II) in endothelium-dependent relaxation and NO synthesis. The effects of three CaMK II inhibitors were investigated in endothelium-intact aortic rings of normotensive rats. NO synthesis was assessed by a NO sensor and chemiluminescence in culture medium of cultured porcine aortic endothelial cells stimulated with the Ca2+ ionophore A23187 and thapsigargin. Rat aortic endothelial NOS activity was measured by the conversion ofl-[3H]arginine tol-[3H]citrulline. Three CaMK II inhibitors, polypeptide 281–302, KN-93, and lavendustin C, attenuated the endothelium-dependent relaxation of endothelium-intact rat aortic rings in response to acetylcholine, A23187, and thapsigargin. None of the CaMK II inhibitors affected the relaxation induced by NO donors. In a porcine aortic endothelial cell line, KN-93 decreased NO synthesis and caused a rightward shift of the concentration-response curves to A23187 and thapsigargin. In rat aortic endothelial cells, KN-93 significantly decreased bradykinin-induced eNOS activity. These results suggest that CaMK II was involved in NO synthesis as a result of Ca2+-dependent activation of eNOS.


Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 3653-3653
Author(s):  
Kesheng Dai ◽  
Rong Yan ◽  
Hong Cheng ◽  
Richard Bodnar ◽  
Changgeng Ruan

Abstract Extracellular domain of platelet glycoprotein (GP) Ibα contains ligand binding sites for von Willebrand factor (VWF) and α-thrombin. GPIbα binding to VWF exposed at the injured vessel initiates thrombus formation, thus it plays key roles in thrombosis and hemostasis. While a lot of research has been performed to elucidate the critical roles for GPIbα in platelet activation, little is known about the negative regulatory mechanisms of this adhesion receptor. Here we show that inhibition of cAMP-dependent protein kinase (PKA) resulted in the shedding of GPIbα from platelet. GPIbα was shed after platelets were incubated with PKA inhibitors (H89, PKI) in a dose-dependent manner. PKA mediated GPIbα shedding was inhibited by calpain inhibitors (MDL 28170, E64d, calpain inhibitor-I, calpain inhibitor-II) in a dose-dependent manor, suggesting that shedding of GPIbα is a result of calpain cleavage. Time course experiment revealed that PKA mediated GPIbα shedding occurred as a late event, 10 minutes after platelet activation. Flow cytometry and western-blot data suggested that the cleavage site was at N-terminal of residues 484 and 485 on GPIbα. These residues are responsible for disulfide bond linkage to GPIbβ. Though the size of GPIbα shed fragments from platelet treated with H89 was the same as platelet treated with calcium ionophore A23187 or thrombin, yet the intensity of platelet activation, the amount of GPIbα shedding, and redistribution of GPIbα were different, suggesting that the mechanism of PKA inhibition-initiated GPIbα shedding is different from the shedding caused by A23187 or thrombin. Platelets treated with the PKA inhibitor, H89, presented significant decrease in ristocetin induced platelet aggregation and platelet adhesion on VWF under shear stress. In conclusion, these data provide new evidence that inhibition of PKA results in calpain mediated GPIbα shedding which may play a role in limiting thrombus infinite formation after platelet activation.


2008 ◽  
Vol 412 (2) ◽  
pp. 223-231 ◽  
Author(s):  
Tao Song ◽  
Naoya Hatano ◽  
Toshie Kambe ◽  
Yoshiaki Miyamoto ◽  
Hideshi Ihara ◽  
...  

The mechanisms of NO inhibition of CaMK [Ca2+/CaM (calmodulin)-dependent protein kinase] II activity were studied. In rat pituitary tumour GH3 cells, TRH [thyrotrophin (TSH)-releasing hormone]-stimulated phosphorylation of nNOS [neuronal NOS (NO synthase)] at Ser847 was sensitive to an inhibitor of CaMKs, KN-93, and was enhanced by inhibition of nNOS with 7NI (7-nitroindazole). Enzyme activity of CaMKII following in situ treatment with 7NI was also increased. The in vitro activity of CaMKII was inhibited by co-incubation either with nNOS and L-arginine or with NO donors SNAP (S-nitroso-N-acetyl-DL-penicillamine) and DEA-NONOate [diethylamine-NONOate (diazeniumdiolate)]. Once inhibited by these treatments, CaMKII was observed to undergo full reactivation on the addition of a reducing reagent, DTT (dithiothreitol). In transfected cells expressing CaMKII and nNOS, treatment with the calcium ionophore A23187 further revealed nNOS phosphorylation at Ser847, which was enhanced by 7NI and CaMKII S-nitrosylation. Mutated CaMKII (C6A), in which Cys6 was substituted with an alanine residue, was refractory to 7NI-induced enhancement of nNOS phosphorylation or to CaMKII S-nitrosylation. Furthermore, we could identify Cys6 as a direct target for S-nitrosylation of CaMKII using MS. In addition, treatment with glutamate caused an increase in CaMKII S-nitrosylation in rat hippocampal slices. This glutamate-induced S-nitrosylation was blocked by 7NI. These results suggest that inactivation of CaMKII mediated by S-nitrosylation at Cys6 may contribute to NO-induced neurotoxicity in the brain.


2019 ◽  
Vol 17 (3) ◽  
pp. 249-253
Author(s):  
Liu Chenglong ◽  
Liu Haihua ◽  
Zhang Fei ◽  
Zheng Jie ◽  
Wei Fang

Cancer-induced bone pain is a severe and complex pain caused by metastases to bone in cancer patients. The aim of this study was to investigate the analgesic effect of scutellarin on cancer-induced bone pain in rat models by intrathecal injection of Walker 256 carcinoma cells. Mechanical allodynia was determined by paw withdrawal threshold in response to mechanical stimulus, and thermal hyperalgesia was indicated by paw withdrawal latency in response to noxious thermal stimulus. The paw withdrawal threshold and paw withdrawal latencies were significantly decreased after inoculation of tumor cells, whereas administration of scutellarin significantly attenuated tumor cell inoculation-induced mechanical and heat hyperalgesia. Tumor cell inoculation-induced tumor growth was also significantly abrogated by scutellarin. Ca2+/calmodulin-dependent protein kinase II is a multifunctional kinase with up-regulated activity in bone pain models. The activation of Ca2+/calmodulin-dependent protein kinase II triggers phosphorylation of cAMP-response element binding protein. Scutellarin significantly reduced the expression of phosphorylated-Ca2+/calmodulin-dependent protein kinase II and phosphorylated-cAMP-response element binding protein in cancer-induced bone pain rats. Collectively, our study demonstrated that scutellarin attenuated tumor cell inoculation-induced bone pain by down-regulating the expression of phosphorylated-Ca2+/calmodulin-dependent protein kinase II and phosphorylated-cAMP-response element binding protein. The suppressive effect of scutellarin on phosphorylated-Ca2+/calmodulin-dependent protein kinase II/phosphorylated-cAMP-response element binding protein activation may serve as a novel therapeutic strategy for CIBP management.


1998 ◽  
Vol 67 (2) ◽  
pp. 145-152 ◽  
Author(s):  
Wendy W. Waters ◽  
Pat L. Chen ◽  
Newell H. McArthur ◽  
Pete A. Moreno ◽  
Paul G. Harms

Sign in / Sign up

Export Citation Format

Share Document